3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Multiple Myeloma
26
Prostatic Neoplasms
24
Breast Neoplasms
23
Leukemia, Myeloid, Acute
20
Carcinoma, Non-Small-Cell Lung
20
Lymphoma
19
Melanoma
16
Lymphoma, Non-Hodgkin
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Ovarian Neoplasms
13
Colorectal Neoplasms
12
Wilms Tumor
11
Myelodysplastic Syndromes
10
Hodgkin Disease
10
Squamous Cell Carcinoma of Head and Neck
9
Sarcoma
9
Neoplasm Metastasis
9
Lung Neoplasms
9
Fallopian Tube Neoplasms
9
Carcinoma, Renal Cell
9
Burkitt Lymphoma
9
Rhabdomyosarcoma
8
Rhabdoid Tumor
8
Neoplasms
8
Leukemia
8
Hepatoblastoma
8
Glioma
8
Sarcoma, Ewing
7
Osteosarcoma
7
Neuroectodermal Tumors, Primitive, Peripheral
7
Interventions
vinflunine
1
sacituzumab govitecan
1
Paclitaxel
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Locally Advanced or Metastatic Unresectable Urothelial Cancer
×
30 days
×
Clear all
NCT04527991
2026-06-02
TROPiCS-04
Gilead Sciences
Phase 3
Completed
711 enrolled
25 charts